Mainz Biomed Shares Down 5.7 percent Heres What Happened
MYNZ Stock | USD 7.32 0.40 5.78% |
Slightly above 53% of Mainz Biomed's investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Mainz Biomed BV suggests that some traders are interested. Mainz Biomed's investing sentiment can be driven by a variety of factors including economic data, Mainz Biomed's earnings reports, geopolitical events, and overall market trends.
Mainz |
Mainz Biomed fell 5.7 percent during trading on Monday . The stock traded as low as 0.21 and last traded at 0.23. 3,189,528 shares traded hands during trading, an increase of 158 percent from the average session volume of 1,236,763 shares. The stock had previously closed at 0.24. Mainz Biomed Stock Performance
Read at thelincolnianonline.com
Mainz Biomed Fundamental Analysis
We analyze Mainz Biomed's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mainz Biomed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mainz Biomed based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Ratio
Current Ratio Comparative Analysis
Mainz Biomed is currently under evaluation in current ratio category among its peers. Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Mainz Biomed BV Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Mainz Biomed stock to make a market-neutral strategy. Peer analysis of Mainz Biomed could also be used in its relative valuation, which is a method of valuing Mainz Biomed by comparing valuation metrics with similar companies.
Peers
Mainz Biomed Related Equities
BNR | Burning Rock | 13.61 | ||||
STRRP | Star Equity | 4.34 | ||||
DRIO | DarioHealth Corp | 2.67 | ||||
STIM | Neuronetics | 2.61 | ||||
PRE | Prenetics Global | 2.33 | ||||
NDRA | ENDRA Life | 2.33 | ||||
LAB | Standard Biotools | 1.09 | ||||
FONR | Fonar | 0.99 | ||||
BDSX | Biodesix | 0.74 | ||||
SERA | Sera Prognostics | 0.93 | ||||
MDXH | MDxHealth | 1.01 | ||||
NOTV | Inotiv | 6.21 | ||||
APDN | Applied DNA | 10.00 |
Additional Tools for Mainz Stock Analysis
When running Mainz Biomed's price analysis, check to measure Mainz Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mainz Biomed is operating at the current time. Most of Mainz Biomed's value examination focuses on studying past and present price action to predict the probability of Mainz Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mainz Biomed's price. Additionally, you may evaluate how the addition of Mainz Biomed to your portfolios can decrease your overall portfolio volatility.